These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 32845639)

  • 1. Nanomedicine-Based Approaches for mRNA Delivery.
    Uchida S; Perche F; Pichon C; Cabral H
    Mol Pharm; 2020 Oct; 17(10):3654-3684. PubMed ID: 32845639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining Nanomedicine and Immunotherapy.
    Shi Y; Lammers T
    Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calcium phosphate-based nanosystems for advanced targeted nanomedicine.
    Degli Esposti L; Carella F; Adamiano A; Tampieri A; Iafisco M
    Drug Dev Ind Pharm; 2018 Aug; 44(8):1223-1238. PubMed ID: 29528248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into Active Targeting of Nanoparticles in Drug Delivery: Advances in Clinical Studies and Design Considerations for Cancer Nanomedicine.
    Pearce AK; O'Reilly RK
    Bioconjug Chem; 2019 Sep; 30(9):2300-2311. PubMed ID: 31441642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are existing standard methods suitable for the evaluation of nanomedicines: some case studies.
    Gioria S; Caputo F; Urbán P; Maguire CM; Bremer-Hoffmann S; Prina-Mello A; Calzolai L; Mehn D
    Nanomedicine (Lond); 2018 Mar; 13(5):539-554. PubMed ID: 29381129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical nanotechnology in Egypt: diverse applications and promising outcomes.
    Elzoghby AO
    Nanomedicine (Lond); 2019 Mar; 14(6):649-653. PubMed ID: 30693819
    [No Abstract]   [Full Text] [Related]  

  • 9. Delivery of oligonucleotides with lipid nanoparticles.
    Wang Y; Miao L; Satterlee A; Huang L
    Adv Drug Deliv Rev; 2015 Jun; 87():68-80. PubMed ID: 25733311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shape matters when engineering mesoporous silica-based nanomedicines.
    Hao N; Li L; Tang F
    Biomater Sci; 2016 Apr; 4(4):575-91. PubMed ID: 26818852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers.
    Yan Y; Xiong H; Zhang X; Cheng Q; Siegwart DJ
    Biomacromolecules; 2017 Dec; 18(12):4307-4315. PubMed ID: 29141136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulfonate-modified phenylboronic acid-rich nanoparticles as a novel mucoadhesive drug delivery system for vaginal administration of protein therapeutics: improved stability, mucin-dependent release and effective intravaginal placement.
    Li C; Huang Z; Liu Z; Ci L; Liu Z; Liu Y; Yan X; Lu W
    Int J Nanomedicine; 2016; 11():5917-5930. PubMed ID: 27877038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineering exosomes as refined biological nanoplatforms for drug delivery.
    Luan X; Sansanaphongpricha K; Myers I; Chen H; Yuan H; Sun D
    Acta Pharmacol Sin; 2017 Jun; 38(6):754-763. PubMed ID: 28392567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Smart cancer nanomedicine.
    van der Meel R; Sulheim E; Shi Y; Kiessling F; Mulder WJM; Lammers T
    Nat Nanotechnol; 2019 Nov; 14(11):1007-1017. PubMed ID: 31695150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluating Nanomedicines: Obstacles and Advancements.
    Swierczewska M; Crist RM; McNeil SE
    Methods Mol Biol; 2018; 1682():3-16. PubMed ID: 29039088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of nanoparticles for therapeutics.
    Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
    Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. mRNA-Based Therapeutics - Advances and Perspectives.
    Sergeeva OV; Koteliansky VE; Zatsepin TS
    Biochemistry (Mosc); 2016 Jul; 81(7):709-22. PubMed ID: 27449617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid Nanoparticles and their Application in Nanomedicine.
    Rajabi M; Mousa SA
    Curr Pharm Biotechnol; 2016; 17(8):662-72. PubMed ID: 27087491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanoparticles for nucleic acid delivery: Applications in cancer immunotherapy.
    Mukalel AJ; Riley RS; Zhang R; Mitchell MJ
    Cancer Lett; 2019 Aug; 458():102-112. PubMed ID: 31100411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational nanocarrier design towards clinical translation of cancer nanotherapy.
    Guo D; Ji X; Luo J
    Biomed Mater; 2021 Mar; 16(3):. PubMed ID: 33540386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.